132 related articles for article (PubMed ID: 28643198)
1. Urokinase plasminogen activator protects cardiac myocytes from oxidative damage and apoptosis via hOGG1 induction.
Hohensinner PJ; Takacs N; Kaun C; Thaler B; Krychtiuk KA; Pfaffenberger S; Aliabadi A; Zuckermann A; Huber K; Wojta J
Apoptosis; 2017 Aug; 22(8):1048-1055. PubMed ID: 28643198
[TBL] [Abstract][Full Text] [Related]
2. Human 8-oxoguanine DNA glycosylase suppresses the oxidative stress induced apoptosis through a p53-mediated signaling pathway in human fibroblasts.
Youn CK; Song PI; Kim MH; Kim JS; Hyun JW; Choi SJ; Yoon SP; Chung MH; Chang IY; You HJ
Mol Cancer Res; 2007 Oct; 5(10):1083-98. PubMed ID: 17951408
[TBL] [Abstract][Full Text] [Related]
3. Urokinase-plasminogen activator protects periodontal ligament fibroblast from oxidative induced-apoptosis and DNA damage.
Ahmad Akhoundi MS; Rokn A; Bagheri R; Momeni N; Hodjat M
J Periodontal Res; 2018 Oct; 53(5):861-869. PubMed ID: 29920670
[TBL] [Abstract][Full Text] [Related]
4. Mitochondria-targeted Ogg1 and aconitase-2 prevent oxidant-induced mitochondrial DNA damage in alveolar epithelial cells.
Kim SJ; Cheresh P; Williams D; Cheng Y; Ridge K; Schumacker PT; Weitzman S; Bohr VA; Kamp DW
J Biol Chem; 2014 Feb; 289(9):6165-76. PubMed ID: 24429287
[TBL] [Abstract][Full Text] [Related]
5. Oncogenic role of p53 is suppressed by si-RNA bicistronic construct of uPA, uPAR and cathepsin-B in meningiomas both in vitro and in vivo.
Gupta R; Rao Gogineni V; Nalla AK; Chetty C; Klopfenstein JD; Tsung AJ; Mohanam S; Rao JS
Int J Oncol; 2011 Apr; 38(4):973-83. PubMed ID: 21290090
[TBL] [Abstract][Full Text] [Related]
6. Urokinase induces survival or pro-apoptotic signals in human mesangial cells depending on the apoptotic stimulus.
Tkachuk N; Kiyan J; Tkachuk S; Kiyan R; Shushakova N; Haller H; Dumler I
Biochem J; 2008 Oct; 415(2):265-73. PubMed ID: 18564064
[TBL] [Abstract][Full Text] [Related]
7. Compensatory effects of hOGG1 for hMTH1 in oxidative DNA damage caused by hydrogen peroxide.
Ke Y; Lv Z; Yang X; Zhang J; Huang J; Wu S; Li YR
Toxicol Lett; 2014 Oct; 230(1):62-8. PubMed ID: 25127756
[TBL] [Abstract][Full Text] [Related]
8. siRNA-mediated simultaneous downregulation of uPA and its receptor inhibits angiogenesis and invasiveness triggering apoptosis in breast cancer cells.
Subramanian R; Gondi CS; Lakka SS; Jutla A; Rao JS
Int J Oncol; 2006 Apr; 28(4):831-9. PubMed ID: 16525631
[TBL] [Abstract][Full Text] [Related]
9. Suppression of urokinase plasminogen activator receptor inhibits proliferation and migration of pancreatic adenocarcinoma cells via regulation of ERK/p38 signaling.
Xue A; Xue M; Jackson C; Smith RC
Int J Biochem Cell Biol; 2009; 41(8-9):1731-8. PubMed ID: 19433314
[TBL] [Abstract][Full Text] [Related]
10. Chronic doxorubicin cardiotoxicity is mediated by oxidative DNA damage-ATM-p53-apoptosis pathway and attenuated by pitavastatin through the inhibition of Rac1 activity.
Yoshida M; Shiojima I; Ikeda H; Komuro I
J Mol Cell Cardiol; 2009 Nov; 47(5):698-705. PubMed ID: 19660469
[TBL] [Abstract][Full Text] [Related]
11. Modulation of cellular migration and survival by c-Myc through the downregulation of urokinase (uPA) and uPA receptor.
Alfano D; Votta G; Schulze A; Downward J; Caputi M; Stoppelli MP; Iaccarino I
Mol Cell Biol; 2010 Apr; 30(7):1838-51. PubMed ID: 20123981
[TBL] [Abstract][Full Text] [Related]
12. The effect of p53-RNAi and p53 knockout on human 8-oxoguanine DNA glycosylase (hOgg1) activity.
Chatterjee A; Mambo E; Osada M; Upadhyay S; Sidransky D
FASEB J; 2006 Jan; 20(1):112-4. PubMed ID: 16293709
[TBL] [Abstract][Full Text] [Related]
13. Induction of p53 by urokinase in lung epithelial cells.
Shetty S; Gyetko MR; Mazar AP
J Biol Chem; 2005 Jul; 280(30):28133-41. PubMed ID: 15937335
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-1alpha enhances the aggressive behavior of pancreatic cancer cells by regulating the alpha6beta1-integrin and urokinase plasminogen activator receptor expression.
Sawai H; Okada Y; Funahashi H; Matsuo Y; Takahashi H; Takeyama H; Manabe T
BMC Cell Biol; 2006 Feb; 7():8. PubMed ID: 16504015
[TBL] [Abstract][Full Text] [Related]
15. Urokinase-induced smooth muscle cell responses require distinct signaling pathways: a role for the epidermal growth factor receptor.
Nicholl SM; Roztocil E; Davies MG
J Vasc Surg; 2005 Apr; 41(4):672-81. PubMed ID: 15874933
[TBL] [Abstract][Full Text] [Related]
16. Urokinase plasminogen activator upregulates paraoxonase 2 expression in macrophages via an NADPH oxidase-dependent mechanism.
Fuhrman B; Khateeb J; Shiner M; Nitzan O; Karry R; Volkova N; Aviram M
Arterioscler Thromb Vasc Biol; 2008 Jul; 28(7):1361-7. PubMed ID: 18436804
[TBL] [Abstract][Full Text] [Related]
17. Suppression of the uPAR-uPA system retards angiogenesis, invasion, and in vivo tumor development in pancreatic cancer cells.
Gorantla B; Asuthkar S; Rao JS; Patel J; Gondi CS
Mol Cancer Res; 2011 Apr; 9(4):377-89. PubMed ID: 21389187
[TBL] [Abstract][Full Text] [Related]
18. Calcitonin inhibits invasion of breast cancer cells: involvement of urokinase-type plasminogen activator (uPA) and uPA receptor.
Han B; Nakamura M; Zhou G; Ishii A; Nakamura A; Bai Y; Mori I; Kakudo K
Int J Oncol; 2006 Apr; 28(4):807-14. PubMed ID: 16525628
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of urokinase-type plasminogen activator receptor induces apoptosis in melanoma cells by activation of p53.
Besch R; Berking C; Kammerbauer C; Degitz K
Cell Death Differ; 2007 Apr; 14(4):818-29. PubMed ID: 17110957
[TBL] [Abstract][Full Text] [Related]
20. The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion.
Hildenbrand R; Schaaf A
Int J Oncol; 2009 Jan; 34(1):15-23. PubMed ID: 19082473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
